lncAP003419.16 is highly expressed in TGFβ1‐treated alveolar epithelial cells and IPF patients,27 in which lncAP003419.16 facilitates pulmonary fibrosis via the mammalian target of rapamycin (mTOR) signaling pathway dependent on its adjacent gene ribosomal protein S6 kinase B‐2 (RPS6KB2). Here, RPS6KB2 is linked to pulmonary fibrosis.